Arbutus Biopharma Corp. (ABUS)

11.32
0.52 4.90
NASDAQ : Health Technology
Prev Close 10.80
Open 10.75
Day Low/High 10.60 / 11.40
52 Wk Low/High 3.20 / 12.05
Volume 417.32K
Avg Volume 346.80K
Exchange NASDAQ
Shares Outstanding 55.17M
Market Cap 645.47M
EPS -1.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Arbutus Announces Topline Results For ARB-1467 Phase II Cohort 4

Arbutus Announces Topline Results For ARB-1467 Phase II Cohort 4

Detailed Data to be Presented at AASLD in October

ABUS Crosses Above Average Analyst Target

ABUS Crosses Above Average Analyst Target

In recent trading, shares of Arbutus Biopharma Corp have crossed above the average analyst 12-month target price of $6.62, changing hands for $6.70/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Arbutus To Host Live Webinar On Developments Of LNP Delivery For MRNA-based Therapeutics

Arbutus To Host Live Webinar On Developments Of LNP Delivery For MRNA-based Therapeutics

An Examination of the Rapidly Emerging field of mRNA Therapeutics in a Live Webinar hosted by the Nucleic Acid Drug Delivery Leader Arbutus Biopharma

TheStreet Quant Rating: E+ (Sell)